Help:WikiPathways Portals
From WikiPathways
(Difference between revisions)
(removed the word portal) |
Current revision (13:11, 13 April 2022) (view source) |
||
| (10 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area. The main advantages of portals include: | + | {| class="wikitable sortable" style="float:right; margin-left: 100px;" |
| - | * | + | |- |
| + | |<h2 class="frontPagePanel blueFg">Community Featured Pathways IEM</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation:IEM | true}} | ||
| + | |- | ||
| + | |<h2 class="frontPagePanel blueFg">Community Featured Pathways COVID-19</h2>{{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Curation:COVID19 | true}} | ||
| + | |} | ||
| + | |||
| + | Portals within WikiPathways serve as organizing points for communities with focused pathway interests. | ||
| + | For example, a portal could organize pathways for a particular species or research area. | ||
| + | |||
| + | The main advantages of portals include: | ||
| + | * Simplified drawing and collecting your pathways | ||
* Help to keep track of ‘works-in-progress’ with collaborators | * Help to keep track of ‘works-in-progress’ with collaborators | ||
* Help attribute credit for pathway authors and curators | * Help attribute credit for pathway authors and curators | ||
| Line 6: | Line 16: | ||
* Help to define a community | * Help to define a community | ||
| - | <br>Creating a portal is easy using existing templates available from WikiPathways. If you are interested, please [https://docs.google.com/document/d/176BshTLE97V-gjzWrt0cgZEpQwnGUI86NdTaatETeSU/edit?pli=1#heading=h.b85xd25jlcie consult the portal maintenance guide] and [[Contact_Us|contact us]] for assistance. | + | <br>Creating a portal is easy using existing templates available from WikiPathways. |
| + | |||
| + | If you are interested, please [https://docs.google.com/document/d/176BshTLE97V-gjzWrt0cgZEpQwnGUI86NdTaatETeSU/edit?pli=1#heading=h.b85xd25jlcie consult the portal maintenance guide] and [[Contact_Us|contact us]] for assistance. | ||
<br>WikiPathways has a growing list of portals: | <br>WikiPathways has a growing list of portals: | ||
| - | |||
* [[Portal:AOP|Adverse Outcome Pathway]] | * [[Portal:AOP|Adverse Outcome Pathway]] | ||
| - | * [[Portal: | + | * [[Portal:IEM|Inherited Metabolic Disorders (IMDs), or Inborn Errors of Metabolism (IEM)]] |
| - | * [[Portal: | + | * [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] |
| - | * [[Portal: | + | * [[Portal:Disease/COVIDPathways|COVID-19]] |
| - | * [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium | + | * [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium, CPTAC]] |
| - | * [[Portal: | + | * [[Portal:Disease|Disease]] |
| - | * [[Portal: | + | * [[Portal:ExRNA|ExRNA]] |
| - | * [[Portal: | + | * [[Portal:Lipids|Lipids]] |
* [[Portal:Micronutrient|Micronutrients]] | * [[Portal:Micronutrient|Micronutrients]] | ||
| - | * [[Portal:Nanomaterials|Nanomaterials | + | * [[Portal:Nanomaterials|Nanomaterials]] |
* [[Portal:NetPath|NetPath]] | * [[Portal:NetPath|NetPath]] | ||
* [[Portal:Plants|Plant Pathways]] | * [[Portal:Plants|Plant Pathways]] | ||
| + | * [[Portal:RareDisease|Rare Disease]] | ||
| + | * [[Portal:RenalGenomics|Renal Genomics]] | ||
* [[Portal:Reactome|Reactome]] | * [[Portal:Reactome|Reactome]] | ||
| - | * [[Portal: | + | * [[Portal:SkeletalDysplasia|Skeletal Dysplasia]] |
| - | * [[Portal: | + | * [[Portal:WormBase|WormBase]] |
[[Category:Portals]] | [[Category:Portals]] | ||
Current revision
Community Featured Pathways IEMRiboflavin and CoQ disorders (Homo sapiens) Image does not exist Riboflavin and CoQ disorders |
Community Featured Pathways COVID-19Physiopathology of endothelial dysfunction in coronavirus disease (Homo sapiens) Image does not exist Physiopathology of endothelial dysfunction in coronavirus disease |
Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area.
The main advantages of portals include:
- Simplified drawing and collecting your pathways
- Help to keep track of ‘works-in-progress’ with collaborators
- Help attribute credit for pathway authors and curators
- Attract new collaborators
- Help to define a community
Creating a portal is easy using existing templates available from WikiPathways.
If you are interested, please consult the portal maintenance guide and contact us for assistance.
WikiPathways has a growing list of portals:
- Adverse Outcome Pathway
- Inherited Metabolic Disorders (IMDs), or Inborn Errors of Metabolism (IEM)
- California Institute for Regenerative Medicine, CIRM
- COVID-19
- Clinical Proteomic Tumor Analysis Consortium, CPTAC
- Disease
- ExRNA
- Lipids
- Micronutrients
- Nanomaterials
- NetPath
- Plant Pathways
- Rare Disease
- Renal Genomics
- Reactome
- Skeletal Dysplasia
- WormBase
